Recruiting
Phase 2

Phase 2a Study of VTX3232 in Parkinson's Disease

Sponsor:

Zomagen Biosciences, Ltd

Code:

NCT06556173

Conditions

Idiopathic Parkinson Disease

Eligibility Criteria

Sex: All

Age: 40 - 70+

Healthy Volunteers: Not accepted

Interventions

VTX3232

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information